Last reviewed 2026-04-19 · How we verify

[14C]-TAK-906 Intravenous Infusion

Millennium Pharmaceuticals, Inc. · Phase 1 active Small molecule

[14C]-TAK-906 Intravenous Infusion is a Small molecule drug developed by Millennium Pharmaceuticals, Inc.. It is currently in Phase 1 development.

At a glance

Generic name	[14C]-TAK-906 Intravenous Infusion
Sponsor	Millennium Pharmaceuticals, Inc.
Modality	Small molecule
Phase	Phase 1

Approved indications

No approved indications tracked.

Common side effects

No common side effects on file.

Competitive intelligence

For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:

[14C]-TAK-906 Intravenous Infusion CI brief — competitive landscape report
[14C]-TAK-906 Intravenous Infusion updates RSS · CI watch RSS
Millennium Pharmaceuticals, Inc. portfolio CI

Frequently asked questions about [14C]-TAK-906 Intravenous Infusion

What is [14C]-TAK-906 Intravenous Infusion?

[14C]-TAK-906 Intravenous Infusion is a Small molecule drug developed by Millennium Pharmaceuticals, Inc..

Who makes [14C]-TAK-906 Intravenous Infusion?

[14C]-TAK-906 Intravenous Infusion is developed by Millennium Pharmaceuticals, Inc. (see full Millennium Pharmaceuticals, Inc. pipeline at /company/millennium-pharmaceuticals-inc).

What development phase is [14C]-TAK-906 Intravenous Infusion in?

[14C]-TAK-906 Intravenous Infusion is in Phase 1.

Manufacturer: Millennium Pharmaceuticals, Inc. — full pipeline
Compare: [14C]-TAK-906 Intravenous Infusion vs similar drugs
Pricing: [14C]-TAK-906 Intravenous Infusion cost, discount & access